PMV Pharmaceuticals, Inc. (PMVP)
NASDAQ: PMVP · IEX Real-Time Price · USD
1.710
+0.020 (1.18%)
At close: Apr 25, 2024, 4:00 PM
1.720
+0.010 (0.58%)
After-hours: Apr 25, 2024, 5:37 PM EDT
PMV Pharmaceuticals Market Cap
PMV Pharmaceuticals has a market cap or net worth of $87.97 million as of April 25, 2024. Its market cap has decreased by -56.52% in one year.
Market Cap
87.97M
Enterprise Value
-102.62M
1-Year Change
-56.52%
Ranking
Category
Stock Price
$1.71
Market Cap Chart
Since the IPO on September 25, 2020, PMV Pharmaceuticals's market cap has decreased from $773.99M to $87.97M, a decrease of -88.63%. That is a compound annual growth rate of -45.52%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 24, 2024 | 86.90M | -6.46% |
Apr 23, 2024 | 92.90M | 4.38% |
Apr 22, 2024 | 89.00M | 7.49% |
Apr 19, 2024 | 82.80M | -0.60% |
Apr 18, 2024 | 83.30M | 0.60% |
Apr 17, 2024 | 82.80M | 0.61% |
Apr 16, 2024 | 82.30M | -2.14% |
Apr 15, 2024 | 84.10M | -8.69% |
Apr 12, 2024 | 92.10M | 13.28% |
Apr 11, 2024 | 81.30M | 4.63% |
Apr 10, 2024 | 77.70M | -4.43% |
Apr 9, 2024 | 81.30M | 1.25% |
Apr 8, 2024 | 80.30M | -2.43% |
Apr 5, 2024 | 82.30M | - |
Apr 4, 2024 | 82.30M | -5.94% |
Apr 3, 2024 | 87.50M | -4.99% |
Apr 2, 2024 | 92.10M | 0.55% |
Apr 1, 2024 | 91.60M | 4.69% |
Mar 28, 2024 | 87.50M | 3.06% |
Mar 27, 2024 | 84.90M | -0.59% |
Mar 26, 2024 | 85.40M | -2.40% |
Mar 25, 2024 | 87.50M | 0.69% |
Mar 22, 2024 | 86.90M | -1.81% |
Mar 21, 2024 | 88.50M | 3.03% |
Mar 20, 2024 | 85.90M | -1.15% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Vivani Medical | 96.06M |
Elicio Therapeutics | 95.16M |
Genelux | 95.10M |
ProPhase Labs | 95.10M |
Allakos | 94.90M |
Elutia | 92.79M |
Milestone Pharmaceuticals | 89.29M |
Aclaris Therapeutics | 88.66M |